PPARA and hyperlipidemia: Although our results demonstrate that IXN has anti‐hyperlipidemia effects by activating AMPK/PPARα and PI3K/AKT pathways to mitigate lipid accumulation and oxidative stress, it is imperative to recognize certain limitations.